Antimicrobial susceptibility of the 76
Organism and antimicrobial agent | MIC (μg/mL) | Susceptibility (%) | ||||
---|---|---|---|---|---|---|
Range | 50% | 90% | S | I | R | |
Penicillin G | ≤0.12–0.25 | ≤0.12 | 0.25 | 100 | 0 | 0 |
Piperacillin-tazobactam | ≤0.12 | ≤0.12 | ≤0.12 | 100 | 0 | 0 |
Cefoxitin | ≤0.12–1 | 0.25 | 1 | 100 | 0 | 0 |
Cefotetan | ≤0.12–0.25 | ≤0.12 | 0.25 | 100 | 0 | 0 |
Ceftriaxone | ≤0.12–0.5 | ≤0.12 | 0.5 | 100 | 0 | 0 |
Imipenem | ≤0.12 | ≤0.12 | ≤0.12 | 100 | 0 | 0 |
Clindamycin | ≤0.12 | ≤0.12 | ≤0.12 | 100 | 0 | 0 |
Moxifloxacin | ≤0.12–0.25 | ≤0.12 | 0.25 | 100 | 0 | 0 |
Chloramphenicol | 0.5–1 | 1 | 1 | 100 | 0 | 0 |
Metronidazole | ≤0.12–0.5 | ≤0.12 | 0.5 | 100 | 0 | 0 |
Penicillin G | ≤0.12 | ≤0.12 | ≤0.12 | 100 | 0 | 0 |
Piperacillin-tazobactam | ≤0.12–0.25 | ≤0.12 | ≤0.12 | 100 | 0 | 0 |
Cefoxitin | ≤0.12–1 | ≤0.12 | 1 | 100 | 0 | 0 |
Cefotetan | ≤0.12–2 | ≤0.12 | 2 | 100 | 0 | 0 |
Ceftriaxone | ≤0.12–0.5 | ≤0.12 | 0.25 | 100 | 0 | 0 |
Imipenem | ≤0.12–1 | ≤0.12 | ≤0.12 | 100 | 0 | 0 |
Clindamycin | ≤0.12 | ≤0.12 | ≤0.12 | 100 | 0 | 0 |
Moxifloxacin | 0.5–2 | 1 | 2 | 100 | 0 | 0 |
Chloramphenicol | 0.25–2 | 1 | 2 | 100 | 0 | 0 |
Metronidazole | ≤0.12–1 | ≤0.12 | 0.5 | 100 | 0 | 0 |
Penicillin G | ≤0.12–1 | 0.25 | 0.5 | 96 | 4 | 0 |
Piperacillin-tazobactam | 1–16 | 4 | 8 | 100 | 0 | 0 |
Cefoxitin | 2–16 | 4 | 16 | 100 | 0 | 0 |
Cefotetan | ≤0.12–64 | 2 | 16 | 92 | 0 | 8 |
Ceftriaxone | 1−>128 | 4 | 8 | 96 | 0 | 4 |
Imipenem | 0.5–2 | 1 | 2 | 100 | 0 | 0 |
Clindamycin | 1−>128 | 4 | 32 | 36 | 16 | 48 |
Moxifloxacin | 2–32 | 4 | 16 | 24 | 52 | 24 |
Chloramphenicol | 2–4 | 4 | 4 | 100 | 0 | 0 |
Metronidazole | ≤0.12–1 | 0.5 | 0.5 | 100 | 0 | 0 |
Penicillin G | ≤0.12–2 | 1 | 2 | 44 | 33 | 22 |
Piperacillin-tazobactam | 0.25–8 | 2 | 8 | 100 | 0 | 0 |
Cefoxitin | 2–8 | 4 | 4 | 100 | 0 | 0 |
Cefotetan | 1–4 | 2 | 4 | 100 | 0 | 0 |
Ceftriaxone | 8−>128 | 64 | 128 | 11 | 22 | 67 |
Imipenem | 0.5–1 | 1 | 1 | 100 | 0 | 0 |
Clindamycin | ≤0.12–0.5 | ≤0.12 | 0.5 | 100 | 0 | 0 |
Moxifloxacin | 0.5–2 | 0.5 | 0.5 | 89 | 0 | 11 |
Chloramphenicol | 0.5–1 | 0.5 | 1 | 100 | 0 | 0 |
Metronidazole | 0.25–1 | 0.25 | 0.5 | 100 | 0 | 0 |
Penicillin G | ≤0.12 | ≤0.12 | ≤0.12 | 100 | 0 | 0 |
Piperacillin-tazobactam | ≤0.12–1 | ≤0.12 | 1 | 100 | 0 | 0 |
Cefoxitin | ≤0.12–0.5 | ≤0.12 | 0.5 | 100 | 0 | 0 |
Cefotetan | ≤0.12–0.25 | ≤0.12 | 0.25 | 100 | 0 | 0 |
Ceftriaxone | ≤0.12 | ≤0.12 | ≤0.12 | 100 | 0 | 0 |
Imipenem | ≤0.12 | ≤0.12 | ≤0.12 | 100 | 0 | 0 |
Clindamycin | ≤0.12–1 | ≤0.12 | 1 | 100 | 0 | 0 |
Moxifloxacin | ≤0.12–16 | 2 | 16 | 75 | 0 | 25 |
Chloramphenicol | 0.5–2 | 0.5 | 2 | 100 | 0 | 0 |
Metronidazole | ≤0.12–0.5 | ≤0.12 | 0.5 | 100 | 0 | 0 |
*
Abbreviations: MIC, minimum inhibitory concentration; S, susceptible; I, intermediate; R, resistant.
© Ann Lab Med